Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 11, 2000

View Archived Issues

Tibolone plus long-term GnRH agonist evaluated in uterine leiomyoma therapy

Thalidomide for therapy of refractory multiple myeloma

Results of interim review support continuation of phase II study evaluating P45

Schering to buy Mitsui Pharmaceuticals

IL-15 potentiates the antiviral response of natural killer cells in vitro

Pharmacia & Upjohn seeks approval for combination glaucoma therapy

FDA grants priority review status to Wyeth-Ayerst's therapy for relapsed adult AML

Cangene revamps Leucotropin clinical trial program

Abbott and NeuroSearch enter nervous system disorder collaboration

Unigene files IND for nasal calcitonin

Organon signs exclusive agreement with CIMA

ADNF III/ADNP antisense oligonucleotides available for licensing from NIH

Neurocrine Biosciences licenses antidiabetic compound to Taisho

New combination therapy for depression with reduced side effects

Human Genome Sciences discloses novel growth-regulatory protein, its production and use

Merck initiates human testing of prophylactic anti-HIV naked DNA vaccine

Millennium reports discovery of apoptosis-linked proteins

16-HETE analogues useful for treating conditions associated with neutrophil adhesion/aggregation

Synthesis and biological activity of new radicicol derivatives presented by Kyowa Hakko

Compounds for osteoporosis in development at Japanese lab

Japanese patent covers new selectin inhibitors useful for inflammatory conditions

Pharmacia & Upjohn and Searle to copromote Detrol

Millennium licenses chronic asthma treatment to Taisho

Once-daily antidiabetic drug from Andrx steadily advances towards market launch

Priority review granted to antihypertensive drug Vanlev

More disappointing clinical results reported for Interneuron's stroke drug

Aventis acquires Hoechst-Ariad Genomics Center

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...